公开(公告)号：US20090028572A1

公开(公告)日：2009-01-29

申请号：US12168523

申请日：2008-07-07

Applicant: Nobuhisa WATANABE

Inventor： Nobuhisa WATANABE

IPC: H04B10/06

CPC classification number: G08C23/04 ,  H04B10/1141

Abstract: A free-space optical receiving apparatus in one embodiment of the invention is provided with: a signal receiving light-sensitive element that converts an infrared signal to an electric current signal; a current-voltage conversion circuit that converts the electric current signal to a voltage signal; a shared processing circuit that amplifies this voltage signal, performs digital conversion on the voltage signal, and outputs a digital signal; and a mode conversion circuit that switches the shared processing circuit to a remote control mode when an infrared signal is received, and switches the shared processing circuit to an IrSimple mode when an IrSimple signal is received. The shared processing circuit converts the remote control signal to a digital signal when in the remote control mode, and converts the IrSimple signal to a digital signal when in the IrSimple mode.

Abstract translation: 在本发明的一个实施例中的自由空间光接收装置具有：将红外信号转换为电流信号的信号接收光敏元件; 将电流信号转换为电压信号的电流 - 电压转换电路; 放大该电压信号的共享处理电路对电压信号进行数字转换，并输出数字信号; 以及当接收到红外信号时将共享处理电路切换到遥控模式的模式转换电路，并且当接收到IrSimple信号时，将共享处理电路切换为IrSimple模式。 当处于远程控制模式时，共享处理电路将遥控信号转换为数字信号，并在IrSimple模式下将IrSimple信号转换为数字信号。

公开(公告)号：US20100127159A1

公开(公告)日：2010-05-27

申请号：US12571797

申请日：2009-10-01

Applicant: Nobuhisa WATANABE

Inventor： Nobuhisa WATANABE

IPC: G01J1/42

CPC classification number: G01J1/02 ,  G01J1/0204 ,  G01J1/0209 ,  G01J1/0214 ,  G01J1/0242 ,  G01J1/0271 ,  G01J1/04 ,  G01J1/044 ,  G01J1/0488 ,  G01J1/4204 ,  G01J1/4228

Abstract: One embodiment of a photodetecting semiconductor apparatus is provided with a sensor chip, a resin-sealed package in which the sensor chip is resin-sealed with a transparent resin, and a color filter disposed on the surface of the sensor chip, with a sensor circuit unit and a light-sensitive element group being formed in the sensor chip. The light-sensitive element group is configured with a color light-sensitive element having a sensitivity peak for color and an infrared light-sensitive element having a sensitivity peak for infrared light. The color light-sensitive element includes a red light-sensitive element having a sensitivity peak for red, a green light-sensitive element having a sensitivity peak for green, and a blue light-sensitive element having a sensitivity peak for blue.

Abstract translation: 光检测半导体装置的一个实施例设置有传感器芯片，其中传感器芯片用透明树脂树脂密封的树脂密封封装和设置在传感器芯片表面上的滤色器，传感器电路 单元和感光元件组形成在传感器芯片中。 感光元件组配置有具有用于颜色的灵敏度峰值的彩色感光元件和具有用于红外光的灵敏度峰值的红外光敏元件。 彩色感光元件包括具有红色灵敏度峰值的红色感光元件，具有用于绿色的灵敏度峰值的绿色感光元件和具有蓝色灵敏度峰值的蓝色感光元件。

公开(公告)号：US20130065925A1

公开(公告)日：2013-03-14

申请号：US13609716

申请日：2012-09-11

Applicant: Ichiro YOSHIDA ,  Tadashi OKABE ,  Yasunobu MATSUMOTO ,  Nobuhisa WATANABE ,  Yuji ONIZAWA ,  Yoshiaki OHASHI ,  Hitoshi HARADA

Inventor： Ichiro YOSHIDA ,  Tadashi OKABE ,  Yasunobu MATSUMOTO ,  Nobuhisa WATANABE ,  Yuji ONIZAWA ,  Yoshiaki OHASHI ,  Hitoshi HARADA

IPC: C07D401/12 ,  A61P1/04 ,  A61K31/4025 ,  A61P1/00 ,  A61K31/454 ,  C07D403/12

CPC classification number: A61K31/4025 ,  A61K31/454 ,  C07D401/12 ,  C07D403/12

Abstract: A compound represented by formula (1) or a pharmaceutically acceptable salt thereof has an inhibitory effect in the fractalkine-CX3CR1 pathway: wherein R represents a C1-6 alkyl group unsubstituted or having 1 to 3 substituents selected from Substituent Group A, a C3-8 cycloalkyl group unsubstituted or having 1 to 3 substituents selected from Substituent Group A, or a C3-8 cycloalkenyl group unsubstituted or having 1 to 3 substituents selected from Substituent Group A, X represents a C1-6 alkyl group, Y and Z are the same or different from each other and each represents a halogen atom or a C1-6 alkyl group unsubstituted or having 1 to 3 substituents selected from Substituent Group B, n represents 0 or 1, Substituent Group A consists of halogen atoms, and Substituent Group B consists of halogen atoms.

Abstract translation: 由式（1）表示的化合物或其药学上可接受的盐具有抑制作用：其中R表示未取代的或具有1至3个选自取代基组A的取代基的C 1-6烷基，C3- 8个未取代的或具有1〜3个选自取代基组A的取代基的环烷基，或未取代或具有1-3个选自取代基组A的取代基的C 3-8环烯基，X表示C 1-6烷基，Y和Z是 相同或不同，各自表示卤素原子或未取代或具有1〜3个选自取代基组B的取代基的C 1-6烷基，n表示0或1，取代基组A由卤素原子和取代基组B 由卤素原子组成。

公开(公告)号：US20100240654A1

公开(公告)日：2010-09-23

申请号：US12791571

申请日：2010-06-01

Applicant: Richard CLARK ,  Shinsuke HIROTA ,  Hiroshi AZUMA ,  Kazunobu KIRA ,  Nobuhisa WATANABE ,  Tadashi NAGAKURA ,  Tatsuo HORIZOE

Inventor： Richard CLARK ,  Shinsuke HIROTA ,  Hiroshi AZUMA ,  Kazunobu KIRA ,  Nobuhisa WATANABE ,  Tadashi NAGAKURA ,  Tatsuo HORIZOE

IPC: A61K31/5377 ,  C07C243/22 ,  A61K31/15 ,  C07D211/72 ,  A61K31/4402 ,  C07D215/38 ,  A61K31/47 ,  C07D239/32 ,  C07D295/28 ,  A61K31/5375 ,  C07D413/04 ,  A61P7/02 ,  A61P9/10 ,  A61P9/00 ,  A61P7/00

CPC classification number: C07D209/48 ,  C07C257/18 ,  C07C311/49 ,  C07C317/14 ,  C07C317/44 ,  C07C337/06 ,  C07D209/08 ,  C07D213/30 ,  C07D213/54 ,  C07D213/71 ,  C07D213/77 ,  C07D213/80 ,  C07D213/82 ,  C07D213/86 ,  C07D213/87 ,  C07D213/89 ,  C07D215/38 ,  C07D233/90 ,  C07D237/20 ,  C07D239/28 ,  C07D239/42 ,  C07D249/18 ,  C07D257/04 ,  C07D295/32 ,  C07D307/68 ,  C07D333/24 ,  C07D471/04

Abstract: A compound represented by the following general formula (1) or a salt thereof or a hydrate of the foregoing is safe while exhibiting suitable physicochemical stability, and is useful as therapeutic or prophylactic agents for diseases associated with thrombus formation. wherein R1a, R1b, R1c and R1d each independently represent hydrogen, etc., R2 represents optionally substituted phenyl, etc., R3 represents optionally substituted C6-10 aryl, etc., Z1, Z2 and Z3 each independently represent hydrogen, etc., Z4 represents hydrogen, etc. and X represents a single bond or —CO—, etc.

Abstract translation: 由下列通式（1）表示的化合物或其盐或其水合物是安全的，同时具有合适的物理化学稳定性，并且可用作与血栓形成相关的疾病的治疗或预防剂。 其中R1a，R1b，R1c和R1d各自独立地表示氢等，R2表示任选取代的苯基等，R 3表示任选取代的C 6-10芳基等，Z 1，Z 2和Z 3各自独立地表示氢等， Z4表示氢等，X表示单键或-CO-等。